A majority of people, including children, persistently experience symptoms like brain fog, fatigue and breathlessness ranging from months to years, post a Covid infection.
The government has no role in the price of these medicines and it has not effected any increase in prices and it has no plans to do so, he said.
The daily positivity rate was at 0.17 per cent and 12 children were among the newly infected people, it said, adding that 46,795 samples were tested in the past 24 hours.
The state now has 822 active cases, while 12,76,782 people have recovered from the disease so far, including 107 in the last 24 hours.
The second worst hit country in terms of cases is India (42,993,494 infections and 515,877 deaths), followed by Brazil (29,391,345 infections and 655,557 deaths).
The number of people who have recuperated from the disease surged to 4,24,46,171 and the case fatality rate was recorded as 1.20 per cent.
The active COVID-19 cases in the country has dipped to 54,118 and comprised 0.13 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.68 per cent, the ministry said.
The second worst hit country in terms of cases is India (42,962,953 infections and 515,036 deaths), followed by Brazil (29,056,525 infections and 652,438 deaths).
The country has also administered over 2 crore precaution doses among the eligible beneficiaries. Additionally, over 97 per cent of India's adult population has also received their first dose of vaccine against Covid-19.
The active cases comprise 0.17 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.65 per cent, the ministry said.
The second worst hit country in terms of cases is India (42,951,556 infections and 514,589 deaths), followed by Brazil (28,978,052 infections and 651,522 deaths).
Of 19 antibodies, 17 were ineffective against the BA.2 subvariant. The researchers found that bebtelovimab, the latest monoclonal antibody to receive FDA Emergency Use Authorisation, is the only currently available antibody therapy that can adequately treat all three Omicron subvariants.
A reduction of 22,056 cases has been recorded in the active COVID-19 caseload in a span of 24 hours.
The US continues to be the worst-hit country with the world's highest number of cases and deaths at 78,476,869 and 935,331, according to the CSSE.
The US continues to be the worst-hit country with the world's highest number of cases and deaths at 78,036,352 and 925,438, according to the CSSE.
Based on the no-objection certificate, Biological E has initiated the clinical study in October 2021 and has evaluated the available safety and immunogenicity results of the ongoing phase 2/3 study, which indicated that the vaccine is safe and immunogenic.
The daily positivity rate was recorded at 7.25 per cent, while the weekly positivity rate was recorded at 9.18 per cent, the ministry said.
The second worst hit country in terms of cases is India (42,188,138 infections and 501,979 deaths), followed by Brazil (26,546,399 infections and 632,514 deaths).
India surpassed the one-crore mark in the number of cases on December 19, 2020, and two crore on May 4 and three crore on June 23 last year.
The nations with a death toll of over 100,000 are Russia (323,452), Mexico (305,762), Peru (205,347), the UK (156,222), Italy (146,149), Indonesia (144,303), Colombia (134,079), Iran (132,424), France (131,576), Argentina (120,988)), Germany (117,734), Ukraine (106,793) and Poland (105,161).
Eligible children in the youngest cohort will get a second dose eight weeks after their first dose and can't receive any vaccination until four weeks after a positive test for coronavirus.
Meanwhile, the health minister will chair a high level review meeting on the present Covid situation with five states on Saturday. Mandaviya will review the public health preparedness and response measures being taken in context of Omicron variant in Bihar, Odisha, Jharkhand, West Bengal, Chhattisgarh through video conferencing.
Citing the study results, Bharat Biotech noted that more than 90 per cent of all individuals boosted with Covaxin showed neutralising antibodies.
Addressing a press conference, Joint Secretary in Health Ministry Lav Agarwal said a sharp rise in COVID-19 infections has been noted in India with the case positivity climbing to 11.05 per cent on Wednesday from 1.1 per cent on December 30.
The second worst hit country in terms of cases is India (35,707,727 infections and 483,936 deaths), followed by Brazil (22,529,183 infections and 620,251 deaths).
Conveying gratitude for the relentless services provided by healthcare workers in managing the pandemic, he said ensuring precaution dose for them and other frontline workers should be taken up in mission mode, it said.
The 73-year-old man, who was found infected with Omicron in genome sequencing and who had tested negative for the infection twice, died in a Udaipur hospital on December 31, Rajasthan government officials had said.
According to the "Guidelines for COVID-19 vaccination of children between 15-18 years and precaution dose to HCWs, FLWs and 60+ population with comorbidities" issued by the health ministry recently, prioritisation and sequencing of the precaution dose for the beneficiaries would be based on the completion of nine months from the date of administration of the second dose, which is 39 weeks.
The trials are being conducted by US-based biotechnology company Gritstone bio in collaboration with the University of Manchester and Manchester University NHS Foundation Trust.
India on Monday logged 33,750 new Covid-19 cases in a span of 24 hours, with an additional 123 fatalities, according to the Union Ministry of Health and Family Welfare. The rise in cases took the active caseload to 1,45,582, and pushed the nationwide death toll to 4,81,893.
As vaccination gradually picked up pace and its scope was expanded, the government battled controversies surrounding its supply and availability to states and union territories and modifying the vaccine purchase and distribution policies.
The other countries with over 5 million cases are the UK (12,277,814), Russia (10,236,301), Turkey (9,335,193), France (9,251,021), Germany (7,028,398), Iran (6,186,729), Spain (5,932,626), Italy (5,678,112), Argentina (5,480,305) and Colombia (5,127,971), the CSSE figures showed.
The CDC has also updated its recommendation of quarantine period for those exposed to Covid-19. For people who are unvaccinated or are more than six months out from their second mRNA dose or more than 2 months after the Johnson & Johnson vaccine, and not yet boosted, CDC recommends quarantine for five days followed by strict mask use for an additional five days, Xinhua news agency reported.
Over 25 lakh eligible beneficiaries between 15-18 years age group in Odisha will start receiving doses from January 3.
The study showed that the prevalence in children aged 12 to 17 years more than halved from 5.35 per cent to 2.31 per cent. As of December 14, 76.6 per cent children at ages 12 to 17 years had received at least one vaccine dose.
With rising scare of probable surge in the Corona infections driven by the newly discovered variant SARS-CoV-2 called Omicron, the Odisha government on Wednesday directed the district level authorities to enhance the daily Covid sample tests in the State to 70000.
A separate study led by a joint team from the IITs Hyderabad and Kanpur is based on the Sutra model, which tracks the country's Covid-19 trajectory.
The other countries with over 5 million cases are the UK (11,518,116), Russia (10,064,290), Turkey (9,191,851), France (8,745,272), Germany (6,834,488), Iran (6,173,369), Spain (5,535,231), Italy (5,405,360), Argentina (5,395,044) and Colombia (5,109,022), the CSSE figures showed.
Most side effects were mild to moderate and transient. Fever was very rare. The most common side effects in the vaccine recipients included pain and tenderness at the injection site, headache, muscle aches and fatigue that lasted a day on average. None of the recipients developed serious reactions like heart inflammation (myocarditis) or blood clots.
Giving details of Omicron cases in India, it said Maharashtra has reported 32 cases of the variant, Delhi (22), Rajasthan (17), Karnataka (8), Telangana (8), Gujarat (5), Kerala (5), Andhra Pradesh (1), Chandigarh (1), Tamil Nadu (1) and West Bengal (1), the government said.